Evaluation of GBV-C/HGV viremia in HIV-infected women;Avaliação da viremia por GBV-C/HGV em mulheres infectadas pelo HIV

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 54, Issue 1, 2012, Pages 31-35

  Silva, Synara Araújo ^a   Rodrigues, Célia Lima ^a   Campos, Aléia Faustino ^a   Levi, José Eduardo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AIDS; Anti HGenv; GBV C; Real time PCR; Viral load

Indexed keywords

GLYCOPROTEIN E2; PROTEIN ANTIBODY; VIRUS RNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; VALIDATION PROCESS; VIREMIA; VIRUS LOAD;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, VIRAL; CD4 LYMPHOCYTE COUNT; FEMALE; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HUMANS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIREMIA;

EID: 84857880632     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652012000100006     Document Type: Article

References (26)

1. Andonov A, Sauder C, Jacobsen H. Chaudhary R. Comparison of six sets of PCR primers from two different genomic regions for amplification of GB virus C/hepatitis G virus RNA. J Clin Microbiol. 1998;36:286-9.
2. Bassit L, Kleter B, Ribeiro-dos-Santos G, Maertens G, Sabino E, Chamone D, et al. Hepatitis G virus: prevalence and sequence analysis in blood donors of São Paulo, Brazil. Vox Sang. 1998;74:83-7.
3. Bortolin MT, Zanussi S, Tedeschi R, Pratesi C, D'Andrea M, Bidoli E, et al. Evaluation of three molecular biology-based assays for the detection of GB virus C/hepatitis G virus in clinical specimens. Intervirology. 2004;47:314-20.
4. Castelain S, Francois C, Bonte D, Baron A, Horle B, Morel, V, et al. Epidemiological and quantitative study of GBV-C infection in French polytransfused children. J Med Virol. 2004;73:596-600.
5. Fan X, Xu Y, Solomon H, Ramrakhiani S, Neuschwander-Tetri BA, Di Bisceglie AM. Is hepatitis G/GB virus-C virus hepatotropic? Detection of hepatitis G/GB virus-C viral RNA in liver and serum. J Med Virol. 1999;58:160-4.
6. Heringlake S, Ockenga J, Tillmann HL, Trautwein C, Meissner D, Stoll M, et al. GB virus C/hepatitis G infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis. 1998;177:1723-6.
7. Lefrère JJ, Lerable J, Mariotti M, Bogard M, Thibault V, Frangeul L, et al. Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay. J Virol Methods. 2000;85:117-24.
8. Lefrère JJ, Loiseau P, Maury J, Lasserre J, Mariotti M, Ravera N, et al. Natural history of GBV-C/hepatitis G virus infection through the follow-up of GBV-C/hepatitis G virus-infected blood donors and recipients studied by RNA polymerase chain reaction and anti-E2 serology. Blood. 1997;90:3776-80.
9. Lefrère JJ, Roudot-Thoraval F, Morand-Joubert L, Petit JC, Lerable J, Thauvin M, et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis. 1999;179:783-9.
10. Levi JE, Fernandes S, Tateno AF, Motta E, Lima LP, Eluf-Neto J, et al. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol. 2004;92:225-31.
11. Levi JE, Contri DG, Lima LP, Takaoka DT, Garrini RH, Santos W, et al. High prevalence of GB virus C/hepatitis G virus RNA among Brazilian blood donors. Rev Inst Med Trop Sao Paulo. 2003;45:75-8.
12. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996;271:505-8.
13. Linnen JM, Fung K, Fry KE, Mizokami M, Ohba K, Wages JM Jr, et al. Sequence variation and phylogenetic analysis of the 5' terminus of hepatitis G virus. J Viral Hepat. 1997;4:293-302.
14. Maidana-Giret MT, Silva TM, Sauer MM, Tomiyama H, Levi JE, Bassichetto KC, et al. GB virus type C infection modulates T-cell activation independently of HIV-1 viral load. AIDS. 2009;23:2277-87.
15. Mohr EL, Stapleton JT. GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepat. 2009;16:757-68.
16. Reshetnyak VI, Karlovich TI, Ilchenko LU. Hepatitis G virus. World J Gastroenterol. 2008;14:4725-34.
17. Simmons JN, Leary TP, Dawson GJ, Pilot-Matias AS, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med. 1995;1:564-9.
18. Souza IE, Allen JB, Xiang J, Klinzman D, Diaz R, Zhang S, et al. Effect of primer selection on estimates of GB virus C (GBV-C) prevalence and response to antiretroviral therapy for optimal testing for GBV-C viremia. J Clin Microbiol. 2006;44:3105-13.
19. Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G, et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet. 1997;349:318-20. Erratum in: Lancet. 1997;349:736.
20. Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med. 2001;345:715-24.
21. Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito, H. Effect of GB virus C/hepatitis G virus co-infection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:209-13.
22. Van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JM, et al. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J Infect Dis. 2005;191:678-85.
23. Williams CF, Klinzman D, Yamashita TE, Xiang J, Polgreen PM, Rinaldo C, et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med. 2004;350:981-90.
24. Xiang J, George SL, Wünschmann S, Chang Q, Klinzman D, Stapleton JT. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1α, MIP-1β, and SDF-1. Lancet. 2004;363:2040-6.
25. Xiang J, Wünschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med. 2001;345:707-14.
26. Zhang W, Chaloner K, Tillmann HL, Williams CF, Stapleton JT. Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis. HIV Medicine. 2006;7:173-80.